Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Close this search box.

Development and Manufacturing Services

Syngene is at the heart of biologics, offering integrated services across the drug discovery, development and manufacturing continuum. We are committed to incrementally adding new layers of expertise to drive continued innovation.  Solving our partners’ complex research and manufacturing problems, has been the hallmark of our success, and sustainable long-term relationships.

A valued partner from start to finish

As a fully integrated custom biomanufacturer, our solutions include mammalian and microbial capabilities for clinical and commercial supplies. We have a strong track record in terms of both experience and know-how across mABs, bispecific, antibody fragments, recombinant proteins, glycoproteins, mRNA, microbial (E. coli and Pichia) and microbiome Live Biotherapeutic Product (LBP).

Quality at the heart of biologics

We have well-established quality management systems and document management systems with electronic records and electronic signature (ERES) compliant equipment. Our facility is also equipped to handle remote audits.

Our biologic manufacturing facility can cater to multi-product production campaigns simultaneously based on single-use technology platform. It is designed to support our clients during long term commercial manufacturing campaigns. We have a wide range of sophisticated and high-end equipment, and rich experience in handling cell culture-based products.

Bioprocess Development

  • Cell line development
  • Developability assessment
  • Process development
  • Viral reduction steps and clearance studies
    • Product characterization:  Mass spectrometry, LC-MS (Glycan and product variants), MALDI-TOF, MS/MS (Ion-trap), CD, fluorescence, SPR (Biacore), PAMAS (sub-vis), Solo VPE, Flowcam, Maurice (cIEF), HIAC
    • Bioassays : Cell based, non-cell based, in vivo, proliferation, inhibition, reporter gene, effector function, secondary signaling
    • Stability studies: Exploratory, freeze-thaw, real-time, accelerated and stress (forced degradation)
  • Formulation screening
  • Non-GMP lab-scale manufacturing

Drug Substance

Our biomanufacturing facility in Bangalore, India, offers end-to-to end, multiple platform technologies and  cGMP manufacturing capabilities for clinical and commercial supply. We employ protocol-driven, technology transfer processes to bring in projects from customers and seamlessly integrate them into our facilities.  We have received successful regulatory inspections from all key regulatory agencies.

Upstream and Downstream processing

Mammalian: Single use systems

  • Scale: 200L/500L and 2000L
  • Upstream: Shake flaks, 1-50L, ambr® 250L, perfusion ATF, Depth and polymeric filtration and centrifugation
  • Downstream: Column chromatography (IEX, Affinity, HIC, AKTA-Process, Explorers and Purifiers). Up to 80mm column and 2000L PH flow rate


  • Scale: 200L to 500L (SS) fermentors, 1000L refolding, 60cm column chromatography and 10 s.q.m tangential flow filtration
  • Upstream: Continuous centrifuge, Cell homogenizer
  • Downstream: Chromatography systems, TFF systems

Drug Product

The demand for sterile fill-finish services has outpaced available capacity, leading to extended wait times and delayed clinical trials for sponsors.

Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for small-scale, sterile drug products having short development timelines. Our facility offers both drug substance and drug product development and manufacturing for biologics.


Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy, Cookies Policy and .

To view or email, Please share your details view

To download, Please share your details